Treatment effects of cladribine tablets on data-driven patterns of regional grey matter atrophy in multiple sclerosis
Mar Barrantes-Cepas(Amsterdam Neuroscience), Menno M. Schoonheim(Amsterdam Neuroscience), Ismail Koubiyr(Université de Bordeaux), Marco Battaglini(University of Siena), Nicola De Stefano(University of Siena), Martijn D. Steenwijk(Amsterdam Neuroscience), Elisa Colato(Amsterdam Neuroscience), Maria Pia Sormani(University of Genoa), Samantha Noteboom(Université de Bordeaux)
Cited by 2
Related Papers
Defining the clinical course of multiple sclerosis
|Neurology|2014|3.1k
MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines
|The Lancet Neurology|2016|863
ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosis
|Multiple Sclerosis Journal|2018|706
2021 MAGNIMS–CMSC–NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis
|The Lancet Neurology|2021|646
Multiple sclerosis progression: time for a new mechanism-driven framework
|The Lancet Neurology|2022|624